NCT02238184View on ClinicalTrials.gov

Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD)

CompletedOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

September 30, 2001

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Atrovent®

DRUG

Ventilat®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02238184 - Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter